Growth hormone and lipids

U. Keller, J. M. Miles

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

It has been known for more than 30 years that growth hormone has a lipolytic properties and growth hormone excess (acromegaly) and growth hormone deficiency have been reported to be associated with abnormalities in serum lipoprotein concentrations. Due to the lipolytic effect of growth hormone, its administration in man has been reported to increase plasma nonesterified fatty acid (NEFA) concentrations. Ketone body production increases during acute growth hormone excess as a result of increased NEFA concentrations; similarly, the increase in serum triglycerides may be explained by an increase in substrate (NEFA) supply to the liver for VLDL production. The effect may be enhanced by a simultaneous decrease of serum lipoprotein lipase activity. The cholesterol-lowering effect of growth hormone administration has not been investigated in detail, specifically, the effect of growth hormone on LDL kinetics is unknown. Growth hormone-excess and growth hormone deficiency have been reported to be associated with increased risk for atherosclerosis; an association with serum lipoprotein changes is likely but evidence for a causal link is yet lacking.

Original languageEnglish (US)
Pages (from-to)36-40
Number of pages5
JournalHormone Research
Volume36
Issue numberSUPPL. 1
StatePublished - 1991
Externally publishedYes

Fingerprint

Growth Hormone
Lipids
Nonesterified Fatty Acids
Serum
Lipoproteins
Ketone Bodies
Acromegaly
Lipoprotein Lipase
Atherosclerosis
Triglycerides
Cholesterol
Liver
Growth hormone excess

Keywords

  • Acromegaly
  • Free fatty acids
  • Growth hormone
  • Insulin
  • Insulin-like growth factor-1
  • Ketone bodies
  • Ketone body kinetics
  • LDL-cholesterol
  • Lipolysis
  • Lipoproteins
  • Pituitary
  • Triglycerides

ASJC Scopus subject areas

  • Endocrinology

Cite this

Keller, U., & Miles, J. M. (1991). Growth hormone and lipids. Hormone Research, 36(SUPPL. 1), 36-40.

Growth hormone and lipids. / Keller, U.; Miles, J. M.

In: Hormone Research, Vol. 36, No. SUPPL. 1, 1991, p. 36-40.

Research output: Contribution to journalArticle

Keller, U & Miles, JM 1991, 'Growth hormone and lipids', Hormone Research, vol. 36, no. SUPPL. 1, pp. 36-40.
Keller U, Miles JM. Growth hormone and lipids. Hormone Research. 1991;36(SUPPL. 1):36-40.
Keller, U. ; Miles, J. M. / Growth hormone and lipids. In: Hormone Research. 1991 ; Vol. 36, No. SUPPL. 1. pp. 36-40.
@article{99ae8188a93c439a8375d4a4cb33c64f,
title = "Growth hormone and lipids",
abstract = "It has been known for more than 30 years that growth hormone has a lipolytic properties and growth hormone excess (acromegaly) and growth hormone deficiency have been reported to be associated with abnormalities in serum lipoprotein concentrations. Due to the lipolytic effect of growth hormone, its administration in man has been reported to increase plasma nonesterified fatty acid (NEFA) concentrations. Ketone body production increases during acute growth hormone excess as a result of increased NEFA concentrations; similarly, the increase in serum triglycerides may be explained by an increase in substrate (NEFA) supply to the liver for VLDL production. The effect may be enhanced by a simultaneous decrease of serum lipoprotein lipase activity. The cholesterol-lowering effect of growth hormone administration has not been investigated in detail, specifically, the effect of growth hormone on LDL kinetics is unknown. Growth hormone-excess and growth hormone deficiency have been reported to be associated with increased risk for atherosclerosis; an association with serum lipoprotein changes is likely but evidence for a causal link is yet lacking.",
keywords = "Acromegaly, Free fatty acids, Growth hormone, Insulin, Insulin-like growth factor-1, Ketone bodies, Ketone body kinetics, LDL-cholesterol, Lipolysis, Lipoproteins, Pituitary, Triglycerides",
author = "U. Keller and Miles, {J. M.}",
year = "1991",
language = "English (US)",
volume = "36",
pages = "36--40",
journal = "Hormone Research in Paediatrics",
issn = "1663-2818",
publisher = "S. Karger AG",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Growth hormone and lipids

AU - Keller, U.

AU - Miles, J. M.

PY - 1991

Y1 - 1991

N2 - It has been known for more than 30 years that growth hormone has a lipolytic properties and growth hormone excess (acromegaly) and growth hormone deficiency have been reported to be associated with abnormalities in serum lipoprotein concentrations. Due to the lipolytic effect of growth hormone, its administration in man has been reported to increase plasma nonesterified fatty acid (NEFA) concentrations. Ketone body production increases during acute growth hormone excess as a result of increased NEFA concentrations; similarly, the increase in serum triglycerides may be explained by an increase in substrate (NEFA) supply to the liver for VLDL production. The effect may be enhanced by a simultaneous decrease of serum lipoprotein lipase activity. The cholesterol-lowering effect of growth hormone administration has not been investigated in detail, specifically, the effect of growth hormone on LDL kinetics is unknown. Growth hormone-excess and growth hormone deficiency have been reported to be associated with increased risk for atherosclerosis; an association with serum lipoprotein changes is likely but evidence for a causal link is yet lacking.

AB - It has been known for more than 30 years that growth hormone has a lipolytic properties and growth hormone excess (acromegaly) and growth hormone deficiency have been reported to be associated with abnormalities in serum lipoprotein concentrations. Due to the lipolytic effect of growth hormone, its administration in man has been reported to increase plasma nonesterified fatty acid (NEFA) concentrations. Ketone body production increases during acute growth hormone excess as a result of increased NEFA concentrations; similarly, the increase in serum triglycerides may be explained by an increase in substrate (NEFA) supply to the liver for VLDL production. The effect may be enhanced by a simultaneous decrease of serum lipoprotein lipase activity. The cholesterol-lowering effect of growth hormone administration has not been investigated in detail, specifically, the effect of growth hormone on LDL kinetics is unknown. Growth hormone-excess and growth hormone deficiency have been reported to be associated with increased risk for atherosclerosis; an association with serum lipoprotein changes is likely but evidence for a causal link is yet lacking.

KW - Acromegaly

KW - Free fatty acids

KW - Growth hormone

KW - Insulin

KW - Insulin-like growth factor-1

KW - Ketone bodies

KW - Ketone body kinetics

KW - LDL-cholesterol

KW - Lipolysis

KW - Lipoproteins

KW - Pituitary

KW - Triglycerides

UR - http://www.scopus.com/inward/record.url?scp=0026320561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026320561&partnerID=8YFLogxK

M3 - Article

C2 - 1806482

AN - SCOPUS:0026320561

VL - 36

SP - 36

EP - 40

JO - Hormone Research in Paediatrics

JF - Hormone Research in Paediatrics

SN - 1663-2818

IS - SUPPL. 1

ER -